Nermina Arifhodžić

539 total citations
27 papers, 428 citations indexed

About

Nermina Arifhodžić is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nermina Arifhodžić has authored 27 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 15 papers in Immunology and Allergy and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nermina Arifhodžić's work include Asthma and respiratory diseases (21 papers), Allergic Rhinitis and Sensitization (13 papers) and Food Allergy and Anaphylaxis Research (7 papers). Nermina Arifhodžić is often cited by papers focused on Asthma and respiratory diseases (21 papers), Allergic Rhinitis and Sensitization (13 papers) and Food Allergy and Anaphylaxis Research (7 papers). Nermina Arifhodžić collaborates with scholars based in Kuwait, Bosnia and Herzegovina and United States. Nermina Arifhodžić's co-authors include Mona Al‐Ahmad, Ashley Woodcock, Adnan Ćustović, Anthony Robinson, Waleed Al–Herz, Hermione Lovel, Nasser Behbehani, Mahmoud Moussa, Ahmed Maher and Ahmed Maher and has published in prestigious journals such as CHEST Journal, Journal of Allergy and Clinical Immunology and Allergy.

In The Last Decade

Nermina Arifhodžić

25 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nermina Arifhodžić Kuwait 11 277 269 138 95 39 27 428
J. Delgado Spain 14 257 0.9× 215 0.8× 149 1.1× 113 1.2× 36 0.9× 45 525
M T Dordal Spain 10 260 0.9× 285 1.1× 67 0.5× 116 1.2× 30 0.8× 24 416
Alfred Priftanji Albania 9 266 1.0× 167 0.6× 93 0.7× 56 0.6× 83 2.1× 14 373
P. Prahl Denmark 17 336 1.2× 290 1.1× 232 1.7× 124 1.3× 51 1.3× 37 653
B. Wüthrich Switzerland 10 141 0.5× 217 0.8× 57 0.4× 101 1.1× 28 0.7× 12 342
Jean A. Chapman United States 9 215 0.8× 410 1.5× 74 0.5× 162 1.7× 90 2.3× 12 594
N Lindholm Sweden 10 339 1.2× 186 0.7× 208 1.5× 64 0.7× 85 2.2× 17 542
M. Gouitaa France 11 188 0.7× 169 0.6× 166 1.2× 72 0.8× 18 0.5× 37 424
Aneta Tomaszewska Poland 12 199 0.7× 230 0.9× 34 0.2× 141 1.5× 17 0.4× 26 367
J. H. Heinig Denmark 16 327 1.2× 158 0.6× 277 2.0× 56 0.6× 49 1.3× 30 512

Countries citing papers authored by Nermina Arifhodžić

Since Specialization
Citations

This map shows the geographic impact of Nermina Arifhodžić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nermina Arifhodžić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nermina Arifhodžić more than expected).

Fields of papers citing papers by Nermina Arifhodžić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nermina Arifhodžić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nermina Arifhodžić. The network helps show where Nermina Arifhodžić may publish in the future.

Co-authorship network of co-authors of Nermina Arifhodžić

This figure shows the co-authorship network connecting the top 25 collaborators of Nermina Arifhodžić. A scholar is included among the top collaborators of Nermina Arifhodžić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nermina Arifhodžić. Nermina Arifhodžić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Ahmad, Mona, et al.. (2021). Peanut Component Ara h 1 and 2 Sensitization in Patients with Food Allergy in Kuwait. International Archives of Allergy and Immunology. 183(3). 315–321. 2 indexed citations
2.
Al‐Ahmad, Mona, et al.. (2019). Sensitization to Cat: When Is Nasal Challenge Needed?. International Archives of Allergy and Immunology. 179(2). 108–113. 11 indexed citations
3.
Al‐Ahmad, Mona, et al.. (2019). Association of molds and metrological parameters to frequency of severe asthma exacerbation. Allergy Asthma and Clinical Immunology. 15(1). 29–29. 21 indexed citations
4.
Košnik, Mitja, et al.. (2019). Curcumin Improves Therapy of Moderate Partially Controlled Asthma: Placebo-controlled, single blind study. PA2532–PA2532. 2 indexed citations
5.
Al‐Ahmad, Mona, et al.. (2018). Most common, real life factors affecting effectiveness of omalizumab asthma treatment: a 10-year study. Medicinski Glasnik. 16(1). 45–52. 5 indexed citations
6.
Al‐Ahmad, Mona, et al.. (2018). "Real-life" Efficacy and Safety Aspects of 4-Year Omalizumab Treatment for Asthma. Medical Principles and Practice. 27(3). 260–266. 19 indexed citations
7.
Al‐Ahmad, Mona, et al.. (2018). Tolerability of Omalizumab in Asthma as a Major Compliance Factor: 10-Year Follow Up. Open Access Macedonian Journal of Medical Sciences. 6(10). 1839–1844. 6 indexed citations
8.
Al‐Ahmad, Mona, et al.. (2016). The Role of Target Organ Diagnostic Approach in Seasonal Allergic Rhinitis: Nasal Smear Eosinophils. Materia Socio Medica. 28(2). 125–125. 5 indexed citations
9.
Al‐Ahmad, Mona, et al.. (2014). Penicillin allergy evaluation: experience from a drug allergy clinic in an Arabian Gulf Country, Kuwait. Asia Pacific Allergy. 4(2). 106–112. 14 indexed citations
11.
Vadas, Peter, et al.. (2010). Catamenial anaphylaxis in three patients. Acta Medica Academica. 39(1). 71–75.
12.
Arifhodžić, Nermina, et al.. (2010). Association and symptom characteristics of irritable bowel syndrome among bronchial asthma patients in Kuwait. Annals of Thoracic Medicine. 5(1). 37–37. 22 indexed citations
13.
Mahmoud, Fadia, et al.. (2009). Intracellular Cytokine Production in Children With Atopic Dermatitis: Effect of Levocetirizine Treatment. 5(2). 162–171. 2 indexed citations
14.
Lovel, Hermione, et al.. (2004). Asthma and sensitization in a community with low indoor allergen levels and low pet-keeping frequency. Journal of Allergy and Clinical Immunology. 114(6). 1389–1394. 69 indexed citations
15.
Arifhodžić, Nermina, et al.. (2004). Salsola pollen as a predominant cause of respiratory allergies in Kuwait. Annals of Allergy Asthma & Immunology. 92(2). 262–267. 54 indexed citations
16.
Arifhodžić, Nermina, et al.. (2004). The Seasonal Variation in Allergic Rhinitis and Its Correlation with Outdoor Allergens in Kuwait. International Archives of Allergy and Immunology. 133(2). 164–167. 30 indexed citations
17.
Arifhodžić, Nermina, et al.. (2003). Safety of Subcutaneous Specific Immunotherapy with Pollen Allergen Extracts for Respiratory Allergy. International Archives of Allergy and Immunology. 132(3). 258–262. 13 indexed citations
18.
Arifhodžić, Nermina, et al.. (2001). Environmental allergens in Kuwait. Allergy. 56(12). 1237–1238. 6 indexed citations
19.
Ćustović, Adnan, Nermina Arifhodžić, Anthony Robinson, & Ashley Woodcock. (1994). Exercise Testing Revisited. CHEST Journal. 105(4). 1127–1132. 74 indexed citations
20.
Arifhodžić, Nermina, et al.. (1989). [Changes in the small joints, skin and lungs in children and adolescents with insulin-dependent diabetes].. PubMed. 43(1). 3–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026